Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.
3 reports, 2 independent
Updated Jul 5
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Foundation commits $24M for therapy development, led by David Liu and Michael P. Boyle, who is CEO of the Foundation.Sub-event
- Cystic Fibrosis Foundation provides up to $24 million in additional funding to Prime Medicine, Inc.Sub-event
Prime Medicine achieved clinical proof-of-concept for CF treatments and is engaging the FDA.1 source
Keep exploring
The entities involved
-
Cystic Fibrosis Foundation
non-profit organization in the USA
Nothing else this week.
-
CGD
Italian record label
Nothing else this week.
Coverage
Newest first; wire copies grouped- yahoo.com
- GlobeNewswirePrime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates -- Announced positive data from two patients in Phase 1/2 clinical trial in Chronic Granulomatous Disease (C
- Unknown outlet